XtalPi Announces $250 Million AI-Powered Drug Discovery Collaboration with Eli Lilly

On May 30, AI pharmaceutical company XtalPi announced a collaboration with Eli Lilly and Company for AI-driven drug discovery, with upfront and milestone payments reaching up to 250 million US dollars. This collaboration will leverage XtalPi’s integrated AI capabilities and robotic platform to design and deliver candidate drugs from scratch for an undisclosed target.